Home > > Global Radiofrequency Ablation Devices Market Report
The Radiofrequency Ablation Devices market was valued at $3,226.2 Million in 2023, and is projected to reach $6,289.9 Million by 2030 growing at a CAGR of 10.08% from 2024 to 2030. Capital Equipment segment is expected to be the highest contributor to this market, with $1,379.5 Million in 2023, and is anticipated to reach $2,756.7 Million by 2030, registering a CAGR of 10.47%. Reusable Equipment segment is anticipated to reach $1,057.4 Million by 2030 with the highest CAGR of 11.41%. Capital Equipment and Disposable Equipment segments collectively expected to account for about 84.6% share of the Radiofrequency Ablation Devices market in 2023, with the former constituting around 42.8% share. Reusable Equipment and Capital Equipment segments are expected to witness significant growth rates at a CAGR of 11.41% and 10.47% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 58.2% in the overall Radiofrequency Ablation Devices market in 2023, and is anticipated to reach 60.6% by 2030. Product Disposable Equipment Capital Equipment Reusable Equipment Application Surgical Oncology Cardiology & Cardiac Rhythm Management Cosmetology Gynecology Pain Management BY REGION North America U.s. Canada Europe Germany U.k. France Italy Spain Rest of Europe Asia China Japan South Korea India Singapore Rest of Asia Middle East & Africa Brazil Mexico South Africa Australia Rest of MENA